Comparison of depressive, anxiety and somatization symptoms in patients with chronic myeloproliferative neoplasms treated with interferon alpha and tyrosine kinase inhibitors
Preview format:
Object preview unavailable
Comparison of depressive, anxiety and somatization symptoms in patients with chronic myeloproliferative neoplasms treated with interferon alpha and tyrosine kinase inhibitors
Preview format:
Object preview unavailable